Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AGEN Agenus > Detailed Quotes

AGEN Agenus

Watchlist
2.700
+0.070+2.66%
Close 11/30 16:00 ET
2.720
+0.020+0.74%
Post Mkt Price 11/30 19:53 ET
High
2.785
Open
2.630
Turnover
14.57M
Low
2.570
Pre Close
2.630
Volume
5.43M
Market Cap
822.99M
P/E(TTM)
Loss
52wk High
3.620
Shares
304.81M
P/E(Static)
Loss
52wk Low
1.250
Float Cap
687.34M
Bid/Ask %
96.49%
Historical High
429.000
Shs Float
254.57M
Volume Ratio
1.69
Historical Low
1.140
Dividend TTM
--
Div Yield TTM
--
P/B
-40.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.13%
Amplitude
8.18%
Avg Price
2.682
Lot Size
1
Float Cap
687.34M
Bid/Ask %
96.49%
Historical High
429.000
Shs Float
254.57M
Volume Ratio
1.69
Historical Low
1.140
Dividend TTM
--
P/B
-40.30
Dividend LFY
--
Turnover Ratio
2.13%
Amplitude
8.18%
Avg Price
2.682
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Listing Date: 02/04/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist